Names and pronunciation
(dye-sye′kloe-meen) Bentyl
Source page 388
Individual generic drug information
Extracted information for dicyclomine only.
(dye-sye′kloe-meen) Bentyl
Source page 388
Func. class.: Gastrointestinal anticho- linergic, antispasmodic
Source page 388
ACTION: Inhibits acetylcholine on receptors, decreases GI motility
Source page 388
USES: IBS
Source page 388
Extracted information for dicyclomine only.
CONTRAINDICATIONS: Hyper- sensitivity to anticholinergics, closed- angle glaucoma, GI obstruction, myas- thenia gravis, paralytic ileus, GI atony, toxic megacolon, dementia
Source page 388
SIDE EFFECTS CNS: Headache, dizziness, fever, insom- nia, drowsiness, confusion, numbness, excitement, restlessness GI: Dry mouth, thirst, constipation, nau- sea, vomiting, distention, paralytic ileus GU: Urinary hesitancy/urgency, ED EENT: Blurred vision, increased IOP, photophobia INTEG: Rash, urticaria, allergic reaction MISC: Heat stroke
Source page 388
INTERACTIONS Increase: side effects—antihistamines, antiparkinson agents, phenothiazines, TCAs, avoid using together Decrease: dicyclomine effect—antacids, use antacids 1 hr prior to product Decrease: effect of anticoagulants—anti- coagulants Decrease: effect of motility agents NURSING CONSIDERATIONS
Source page 388
Extracted information for dicyclomine only.
DOSAGE AND ROUTES • Adult: PO 10-20 mg tid-qid, max 160 mg/day; IM 10-20 mg q6hr; max 1-2 days • Child >2 yr: PO 10 mg tid-qid • Child 6 mo-2 yr: PO 5 mg tid-qid
Source page 388
Available forms: Capsules 10 mg; 20 mg; syrup 10 mg/mL; injection 10 mg/mL
Source page 388
Administer: PO route • Protect from light/heat • Children: Syrup should be diluted with equal volume of water before use IM route • Aspirate prior to use • Do not give IV, SUBCUT
Source page 388
Extracted information for dicyclomine only.
Assess: • IBS symptoms: assess for constipa- tion/diarrhea or both, abdominal pain, bloating, gas. Identify if product is less- ening symptoms • Pregnancy/breastfeeding: used in pregnancy to decrease nausea/vomiting; do not breastfeed • Anticholinergic effects: Monitor for dry mouth, constipation, dizziness • CNS changes: Assess for dizziness, drowsiness; caution against driving or other hazardous activities until response is known • Pregnancy/breastfeeding: Use in preg- nancy only if clearly needed, do not breastfeed
Source page 388
Evaluate: • Therapeutic response • Decreasing abdominal pain, bloating, gas, diarrhea/constipation
Source page 388
Patient and caregiver information: • To report anticholinergic effects • Not to drive or perform other hazard- ous activities until response is known • Pregnancy/breastfeeding: do not breastfeed
Source page 388
Extracted information for dicyclomine only.
PHARMACOKINETICS Onset unknown, peak 1-1½, duration unknown, half-life 1.8 hr
Source page 388
Filter the extracted dose blocks for this individual drug.
• Adult: PO 10-20 mg tid-qid, max 160 mg/day; IM 10-20 mg q6hr; max 1-2 days
Candidate age grouping · source page 388
• Child >2 yr: PO 10 mg tid-qid
Candidate age grouping · source page 388
• Child 6 mo-2 yr: PO 5 mg tid-qid
Candidate age grouping · source page 388